CD8A and breast neoplasm: Breast tumors containing elevated counts of CD8+ lymphocytes with features of tissue-resident memory T-cell differentiation or a high CD8+/FOXP3+ ratio are deeply associated with improved survival after NACT, while the prognostic significance of regulatory T lymphocytes remains controversial [43].